Author:
Mishra Akshay G.,Deshmane Rutuja B.,Thappa Damodar K.,Lona Jeseena,Ghade Nikhil S.,Sonar Sanjay M.,Krishnan Archana R.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,General Medicine,Biotechnology
Reference33 articles.
1. Ghosh S, Bose S, Gowda S, Mukhopadhyay P. Biosimilar insulins—what a clinician needs to know? Indian J Endocrinol Metab. 2019;23(4):400–6. https://doi.org/10.4103/ijem.IJEM_180_19.
2. Dolinar RO, Edelman S, Heinemann L, Home P, Goyal S, Polonsky WH, Schellekens H. Impact of biosimilar insulins on clinical practice: meeting report. J Diabetes Sci Technol. 2014;8(1):179–85. https://doi.org/10.1177/1932296813518267.
3. Rotenstein LS, Ran N, Shivers JP, Yarchoan M, Close KL. Opportunities and challenges for biosimilars: what’s on the horizon in the global insulin market? Clin Diabetes. 2012;30(4):138–50. https://doi.org/10.2337/diaclin.30.4.138.
4. Kirchhoff CF, Wang XM, Conlon HD, Anderson S, Ryan AM, Bose A. Biosimilars: key regulatory considerations and similarity assessment tools. Biotechnol Bioeng. 2017;114(12):2696–705. https://doi.org/10.1002/bit.26438.
5. Guideline on non-clinical and clinical development of similar biological medicinal products containing recombinant human insulin and insulin analogues, EMEA/CHMP/BMWP/32775/2005_Rev. 1. https://www.ema.europa.eu/documents/scientific-guideline/guideline-non-clinical-clinical-development-similar-biological-medicinal-products-containing_en-0.pdf. Accessed 26 Feb 2015.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献